Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award | Professor | Chungbuk National University | South Korea

Prof. Yun-Bae Kim, a distinguished professor at the Department of Toxicology, College of Veterinary Medicine, Chungbuk National University, Republic of Korea, is an eminent scholar in the fields of toxicology, neurobiology, and regenerative medicine. Holding both a Doctor of Veterinary Medicine (D.V.M.) and a Ph.D. in Veterinary Medicine from Seoul National University, Prof. Yun-Bae Kim has built an outstanding academic and research career dedicated to the study of neurotoxicopathology, neurodegenerative diseases, and stem cell-based therapeutic innovations. His research primarily explores the toxicopathologic mechanisms of chemicals, brain aging, and the development of gene-modified stem cells to treat degenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and cerebral palsy. With over 370 peer-reviewed publications and patents indexed in Scopus, PubMed, and other global databases, Prof. Yun-Bae Kim scholarly impact spans across both scientific research and industrial innovation. His professional experience includes serving as a Senior Researcher at the Agency for Defense Development, where he contributed to biomedical and toxicologic defense research, and later as a Visiting Professor at the University of British Columbia Hospital in Canada, where he developed neural stem cells effective against Alzheimer’s dementia. Prof. Yun-Bae Kim research excellence is supported by his leadership roles as CEO of Designed Cells Co., Ltd. in Korea, Vice-Chair of Qingdao Sinder Designed Stem Cells Co., Ltd. in China, Co-Chair of Designed Cells Europe D.O.O. in Croatia, and Chief Scientific Officer of ThanEver Inc. He has also served as Editor-in-Chief of Laboratory Animal Research for a decade and continues to contribute as an editorial board member or associate editor for several prestigious journals such as Molecules, Journal of Ginseng Research, and Journal of Chemical Neuroanatomy. His research interests encompass toxicologic pathology, neuropharmacology, stem cell biotechnology, and regenerative therapies targeting chronic and neurodegenerative conditions. His scientific skills include molecular toxicology, bioinformatics, experimental pathology, and stem cell engineering. Recognized in global directories such as Marquis Who’s Who and 21st Century Korean Roll (Who’s Who), Prof. Yun-Bae Kim has received numerous honors and has contributed extensively to scientific societies and academic collaborations worldwide. His dedication to advancing interdisciplinary biomedical sciences, coupled with his visionary leadership in academia and biotechnology, firmly establishes him as a transformative figure whose continued work promises to enhance global standards in neurotoxicology, regenerative medicine, and therapeutic innovation.

Profile:  Google scholar | Scopus

Featured Publications

  1. Kim, Y.-B., et al. (2024). BVN008, Diphtheria-tetanus-acellular pertussis combined vaccine has no effects on fertility and prenatal and postnatal developmental toxicity in female Sprague-Dawley rats. Reproductive Toxicology, 126, 108587. (1 citation)

  2. Kim, Y.-B., et al. (2024). The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes. Endocrinology.

  3. Kim, Y.-B., et al. (2023). Repeated Intravenous Administration of Human Neural Stem Cells Producing Choline Acetyltransferase Exerts Anti-Aging Effects in Male F344 Rats. Cells, 12(5). (2 citations)

  4. Kim, Y.-B., et al. (2023). An Exosome-Rich Conditioned Medium from Human Amniotic Membrane Stem Cells Facilitates Wound Healing via Increased Reepithelization, Collagen Synthesis, and Angiogenesis. Cells, 12(4). (12 citations)

  5. Kim, Y.-B., et al. (2023). Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology, 12(6). (10 citations)

  6. Kim, Y.-B., et al. (2023). Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes. International Journal of Molecular Sciences, 24(9). (6 citations)

  7. Kim, Y.-B., et al. (2023). Antioxidative and Anti-Inflammatory Activities of Rosebud Extracts of Newly Crossbred Roses. Nutrients, 15(10). (3 citations).

 

Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

  • Inborn errors of metabolism and rare genetic diseases

  • Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)

  • Phenylketonuria (PKU) and organic acidurias

  • Neonatal screening programs

  • Epidemiology and real-world evidence in pediatric metabolic disorders

  • Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

  • Principal Investigator in multiple national and international clinical trials

  • Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD

  • Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN

  • Co-author of educational and clinical monographs, including:

    • “Inherited Metabolic Disorders Neonatal Screening” (2014)

    • Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)

    • Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

Yonghong Li | Public Health | Best Researcher Award

Published on by Research Hypothesis

Yonghong Li | Public Health | Best Researcher Award

Prof Yonghong Li, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, China

Prof. Yonghong Li is an internationally recognized expert in minimally invasive spinal surgery, with a distinguished career in clinical practice, academic leadership, and medical research. He holds MD and PhD degrees from Seoul National University School of Medicine and is a fellow of both the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. As President of Wooridul Spine Hospital and Head of Neurosurgery at Armed Forces Chungpyung Hospital, Prof. Li has been instrumental in advancing endoscopic spine techniques. He serves as Editor-in-Chief of JMISST-Video and holds editorial positions in journals like European Spine Journal and PLOS One. His pioneering research and educational contributions have shaped the global discourse on spine care. Recognized by Marquis Who’s Who with a Lifetime Achievement Award, Prof. Li exemplifies clinical excellence, research innovation, and leadership in the global medical community.

Publication Profile

orcid

Education

Prof. Yonghong Li earned both his MD and PhD from the prestigious Seoul National University School of Medicine, South Korea, laying a solid foundation in neurosurgical and spinal sciences. His academic journey has been marked by consistent pursuit of excellence in spinal health, endoscopic surgical techniques, and clinical innovation. He further distinguished himself by earning fellowships from the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons, reflecting his commitment to international best practices and high-level clinical expertise. This educational background has enabled him to contribute significantly to medical literature and innovation in spinal surgery. His scholarly training, coupled with cross-border accreditations, positions him as a leading authority in spine surgery and a mentor for aspiring neurosurgeons and clinical researchers worldwide.

Experience

Prof. Li’s expansive professional experience spans clinical, academic, and research leadership roles. He is currently the Head of the Department of Neurosurgery at the Armed Forces Chungpyung Hospital and serves as President of Wooridul Spine Hospital. He plays key roles in national and international medical societies, including Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager for the Korean Minimally Invasive Spine Surgery Society. He also sits on the Inter-Ministerial Evaluation Committee for National R&D Projects (IRIS). As Editor-in-Chief of JMISST-Video and editorial board member for European Spine Journal, PLOS One, and Biomed Research International, he actively shapes scientific discourse. With numerous textbook editorships and scholarly contributions, Prof. Li has trained generations of spine surgeons and remains a guiding force in the field of minimally invasive spinal surgery.

Awards and Honors

Prof. Yonghong Li has received numerous accolades in recognition of his groundbreaking contributions to neurosurgery and spinal health. Notably, he was honored with the 2020 Gachon University President’s Special Award for Research Excellence, celebrating his innovations in minimally invasive techniques. In 2018, he received the prestigious Albert Nelson Marquis Lifetime Achievement Award, awarded by MARQUIS Who’s Who, which also listed him in their global registry of top professionals. His remarkable service as a clinical leader and researcher continues to earn global recognition. These awards reflect not only his academic and clinical excellence but also his unwavering commitment to pushing the boundaries of spinal surgery. Prof. Li’s honors affirm his role as a pioneer in the integration of technological innovation with surgical precision, establishing new standards for excellence in the global medical community.

Research Focus

Prof. Li’s research primarily focuses on minimally invasive spine surgery, particularly endoscopic approaches to lumbar and cervical spine conditions. His studies delve into the development of advanced surgical techniques, the learning curves involved, and postoperative outcomes such as pain management and complication rates. He also explores applications of endoscopic surgery in cases of intradural tumors and vertebroplasty-induced stenosis. Beyond surgery, Prof. Li contributes to public health and epidemiology, addressing climate change adaptation behaviors among schoolchildren and evaluating health interventions during heatwaves in China. This multidisciplinary approach bridges clinical innovation and population health, reflecting his dedication to holistic and scalable healthcare improvements. Through textbooks, peer-reviewed articles, and editorial work, Prof. Li has fostered international collaboration and knowledge dissemination, ensuring continuous evolution in spine care. His research continues to impact not only surgical outcomes but also broader medical and environmental health strategies.

Publication Top Notes

Knowledge, Attitude, Risk Perception, and Health-Related Adaptive Behavior of Primary School Children towards Climate Change: A Cross-Sectional Study in China

Effectiveness Evaluation of a Primary School-Based Intervention against Heatwaves in China

Comparison of ARIMA and LSTM in Forecasting the Incidence of HFMD Combined and Uncombined with Exogenous Meteorological Variables in Ningbo, China

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Dr giuseppina malcangi, University of Bari “Aldo Moro, Italy

Dr. Giuseppina Malcangi is a distinguished researcher in dentistry, specializing in oral surgery, implantology, and orthodontics. She has made significant contributions to regenerative dentistry, nanotechnology applications, and platelet-based therapies. With 128+ indexed publications (h-index: 29, 2397 citations), she has earned global recognition. Her groundbreaking work on herbal medicine for oral health, platelet concentrates in facial rejuvenation, and cytokine interactions in orthodontics highlights her innovative approach. In December 2023, she secured the ASN (Abilitazione Scientifica Nazionale) for Associate Professor, affirming her excellence. Her dedication to advancing dentistry through evidence-based research makes her a strong candidate for the Best Researcher Award.

Publication Profile

Orcid

Education & Specialization

Dr. Giuseppina Malcangi earned her Degree in Dentistry and Dental Prosthetics from the University of Bari, Italy, in 1989. She pursued advanced education with 1st and 2nd level International Master’s in Advanced Oral Surgery and Dental Implantology. Further specializing in Orthodontics, she completed her training at the Interdisciplinary Department of Medicine (D.I.M.), Bari University “Aldo Moro.” Her academic foundation integrates surgical expertise, orthodontic precision, and implantology, ensuring a holistic approach to dental treatments. Her dedication to lifelong learning and specialization in innovative techniques has solidified her reputation as a leading expert in dental research and clinical applications. 🎓🦷🔬

Awards & Honors

Dr. Giuseppina Malcangi earned the ASN Associate Professor Qualification in 2023, a testament to her academic excellence. 🏆 A recognized innovator in dentistry, she holds an international patent for groundbreaking research. 🔬📜 With an impressive portfolio of 128+ indexed journal papers (h-index: 29), four book chapters, and over 50 national journal articles, she has made a lasting impact on dental science. 📚✍️ Her research is widely referenced, accumulating 2,397+ citations as of March 2025. 🔍 As a CLOPD Subject Matter Expert, she is highly regarded for her expertise in oral health sciences. 🏛️ Her commitment to advancing dentistry is evident in her extensive contributions, including high-impact publications, patents, and academic leadership. Through innovation and scholarly excellence, she continues to push the boundaries of dental science, influencing the next generation of researchers and practitioners. 🏅🔬📖

Research Focus

Dr. Malcangi’s research delves into cutting-edge advancements in dentistry, integrating modern technology with traditional practices to enhance patient outcomes. 💡📖🦷 Her work in regenerative dentistry explores the use of stem cells for oral tissue regeneration, offering innovative solutions for dental repair. 🧬🦷 She also pioneers nanotechnology applications, improving the durability and functionality of dental materials. 🏗️🔬 Additionally, she investigates the role of herbal medicine in oral health, developing natural anti-inflammatory treatments for gum diseases. 🌿🩺 Her studies on platelet concentrates and growth factors focus on their applications in facial rejuvenation, contributing to aesthetic and therapeutic advancements. 💉💆‍♀️ Furthermore, her research on cytokine interactions in orthodontics enhances treatment efficiency, optimizing patient care. 🔄😬 By bridging traditional methods with state-of-the-art innovations, Dr. Malcangi continues to shape the future of dentistry, driving progress in both research and clinical practice. 🏅🔬📖

Publication Top Notes

Effectiveness of Herbal Medicines with Anti-Inflammatory, Antimicrobial, and Antioxidant Properties in Improving Oral Health and Treating Gingivitis and Periodontitis: A Systematic Review

The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series

The Diagnosis and Management of Infraoccluded Deciduous Molars: A Systematic Review

Stem Cells: Present Understanding and Prospects for Regenerative Dentistry

Nanotechnology and Its Application in Dentistry: A Systematic Review of Recent Advances and Innovations

The Effectiveness of Curcumin in Treating Oral Mucositis Related to Radiation and Chemotherapy: A Systematic Review

The Use of Platelet-Rich Fibrin (PRF) in the Management of Dry Socket: A Systematic Review

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Wei Liu Hunan, University of Chinese Medicine, China

Prof. Dr. Wei Liu is a distinguished scholar in Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, serving as Deputy Dean at Hunan University of Chinese Medicine. With a Ph.D. in Engineering 🎓, he has made groundbreaking contributions through 100+ research papers 📄 (30+ indexed in SCI/EI), 2 monographs 📚, and 9 textbooks 📖. His 30+ software copyrights 💡 and leadership in 20+ major projects 🚀, including collaborations with Huawei and national research foundations, solidify his expertise. As a Young Backbone Teacher of Hunan Province, he also excels in mentoring, guiding students to 300+ awards 🏅, including 10+ national gold prizes 🏆. His teaching innovation has earned him national and provincial-level honors, while his contributions to Traditional Chinese Medicine (TCM) Informatics 🌿 further highlight his multidisciplinary excellence. Recognized as a National Certified System Architect 🏗️, SCI journal reviewer 🧐, and a member of CCF, ACM, and CAIS, Prof. Liu is a true leader in his field.

Publication Profile

Scopus

Education

Prof. Dr. Wei Liu holds a Ph.D. in Engineering (Computer Application Technology) 🖥️ from a prestigious institution, where he specialized in Artificial Intelligence 🤖 and Medical Informatics 🏥. His doctoral research focused on intelligent software systems, integrating machine learning 📊 with healthcare applications 🏩. Prior to his Ph.D., he completed his Master’s degree 🎓 in Computer Science, gaining deep expertise in data-driven decision-making 💾 and intelligent algorithms 🔍. His academic journey also includes undergraduate studies in Software Engineering 💡, where he built a strong foundation in computational intelligence 🧠, biomedical computing 🏥, and software development 💻. With an interdisciplinary education spanning engineering, computer science, and informatics, Prof. Liu combines technical depth with practical innovation, making his academic background perfectly suited for pioneering AI-driven healthcare solutions 🚑. His commitment to education 📚 continues as he mentors students and professionals in next-generation AI research and applications 🤖📊.

Experience

Prof. Dr. Wei Liu serves as the Deputy Dean of the School of Informatics 🏛️ at Hunan University of Chinese Medicine, leading research in Artificial Intelligence 🤖, Medical Informatics 🏥, and Software Engineering 💻. As a Professor and Senior Engineer 👨‍🔬, he supervises Master’s students 🎓, guiding them in cutting-edge AI research 🚀. With a rich teaching career 📚, he has developed three top-level provincial courses 🎖️ and ranked 1st in the Hunan Provincial Teaching Competition 🏆. His industry collaborations with Huawei and leadership in 20+ national projects 🏗️ highlight his practical impact 🌍. He actively contributes as a Vice President of the Hunan Association for TCM Informatics 🌿 and serves on multiple national AI and computing committees 🤝. His work as an SCI journal reviewer 🧐 and National Certified System Architect 🏗️ ensures that his research, teaching, and innovation continue to shape the future of AI-driven medical solutions 🔬.

Awards & Honors

Prof. Dr. Wei Liu is a distinguished researcher and educator 🌟, renowned for his contributions to AI, medical informatics, and teaching innovation 📚. His accolades include the National Teaching Innovation Competition Second Prize 🏆 (2024), 1st Place in the Hunan Provincial Teaching Competition 🎖️, and the National TCM Informatics Teaching Gold Prize 🏅. He has been honored as the “Most Knowledgeable Young Teacher” in Hunan Province 🏆 and recognized as a Young Backbone Teacher 👨‍🏫. A recipient of the Huawei Industry-Academia Collaboration Excellence Award 🏅, he also serves as an Executive Member of National AI Committees 🤖. His mentorship has led students to win 300+ awards 🏆, including over 10 national gold prizes 🥇. As a pioneer in AI-driven medical technologies 🌍, his impact extends across academia and industry 🚀.

Research Focus

Prof. Dr. Wei Liu’s research spans Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, focusing on AI-driven healthcare solutions 📊, big data analysis 🏩, and intelligent diagnosis 🏥. His expertise includes AI-based disease prediction, NLP for medical data 📜, deep learning for medical imaging 🧠📸, and IoT-driven smart healthcare 🚑. Integrating AI with Traditional Chinese Medicine 🌿🤖, he pioneers innovative patient care solutions. With 30+ software copyrights 💡, 100+ high-impact publications 📄, and national-level projects—including Huawei collaborations 🚀—his work enhances precision medicine, diagnostics, and medical software applications 🌍, revolutionizing healthcare technology.

Publication Top Notes

Recognition of Hand-Drawn Hydrocarbon Structure Formulas Using Anchor-Free Detector

Classification of cold and hot medicinal properties of Chinese herbal medicines based on graph convolutional network

ChemReco: automated recognition of hand-drawn carbon–hydrogen–oxygen structures using deep learning

SQCS: A sustainable quality control system for spatial crowdsourcing via three-party evolutionary game: Theory and practice

Truth based three-tier Combinatorial Multi-Armed Bandit ecosystems for mobile crowdsensing

YoDe-Segmentation: automated noise-free retrieval of molecular structures from scientific publications

 

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Dr VIVEKANAND ASHOK, Azeezia Health City, India

Dr. Vivekanand Ashok is a dedicated otorhinolaryngologist with a passion for research and surgical excellence. His extensive work spans cochlear implants, otologic surgeries, and head and neck disorders. With numerous high-impact publications in esteemed journals, his research has significantly contributed to advancements in ENT care. His clinical expertise in endoscopic sinus surgery, thyroid disorders, and voice disorders, combined with his academic contributions, makes him a deserving candidate for the Best Researcher Award. His continuous pursuit of innovation in ENT treatments, active participation in conferences, and commitment to medical education further solidify his reputation as an outstanding researcher. 🏅📚🔬

Publication Profile

Orcid

Education

Dr. Vivekanand Ashok 🎓 pursued his MBBS from Azezia Institute of Medical Sciences, Kerala (2014) 🏥📖, followed by an M.S in ENT from Bangalore Medical College and Research Institute, Karnataka (2020) 🎓🩺. He further obtained a DNB (ENT) in 2021 🏅📚 and completed a Fellowship in Cochlear Implant Surgery at GMERS Gandhinagar in 2023 🎧🔬. With a strong foundation in otorhinolaryngology, he specializes in ENT surgeries and cochlear implants, demonstrating his dedication to patient care. His rigorous training at top institutions has equipped him with expertise in handling complex ENT cases, establishing him as a leader in the field. 📘💉🔍

Experience

Dr. Vivekanand Ashok is a distinguished ENT specialist with extensive experience in medical education, clinical practice, and research. He served as a Senior Resident at Karnataka Institute of Medical Sciences (2020-2021) 🏨👨‍⚕️ and Malabar Cancer Centre, Kerala (2021-2022) 🎗️🏥, honing his expertise in otolaryngology. Transitioning into academia, he worked as an Assistant Professor at Karuna Medical College, Kerala (2022-2024) 🎓📖, shaping future medical professionals. Currently, he excels as a Senior Consultant at Co-operative Hospital, Kattappana (2024-2025) 🏨🩺 and Azeezia Health City, Palakkad (2025-Present) ⚕️🔬. His dedication to patient care and surgical excellence makes him a respected figure in the field. 🏆👨‍⚕️

Awards & Honors

Dr. Vivekanand Ashok’s dedication to academic excellence and research has earned him prestigious accolades in the field of ENT. He secured 3rd position in the South Zone ENT Quiz (2018) 🥉🧠, demonstrating his deep knowledge and expertise. In 2019, he was a Zonal Round Participant in the South Zone Young Scholar Award 🎖️📖, further highlighting his commitment to continuous learning and professional growth. These achievements reflect his passion for advancing medical knowledge and contributing to the field of otolaryngology. Through his dedication to research and education, Dr. Ashok continues to make a significant impact in the medical community. 🏆🔬

Research Focus

Dr. Ashok specializes in otorhinolaryngology, cochlear implants, head and neck surgery, and otologic diseases. His research focuses on laryngopharyngeal reflux, rhino-orbital mucormycosis, thyroid carcinomas, and nasal hemangiomas. His work has contributed to improving diagnostic techniques and treatment approaches in ENT disorders. With a passion for innovation, he continues to explore advancements in hearing restoration, sinus surgery, and minimally invasive ENT procedures. 🎧👂📊

Publication Top Notes

Unmasking the Fungal Menace: A Case Report of Chronic Granulomatous Invasive Fungal Sinusitis of Maxilla

Clinical features, diagnosis, and treatment outcome of Rhino-orbito-cerebral mucormycosis: A 2-year experience at a tertiary care center

Extrapulmonary head and neck tuberculosis: 3 year experience at a tertiary care centre

Nasal haemangioma as a cause of epistaxsis: a case report

Laryngopharyngeal reflex – Diagnosis and management at atertiary care centre

Nasal cavity extramedullary plasmacytoma: literature review and clinical experience

Lei Tong | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Lei Tong | Medicine and Health Sciences | Best Researcher Award

Dr Lei Tong, China Academy of Chinese Medical Sciences, China

Dr. Aayushi 🧪🎓 is a highly accomplished researcher in Chemical Sciences, securing an All India Rank of 02 in CSIR NET (Dec 2023) 🏆. She qualified IIT JAM (2017) and received prestigious scholarships, including the CBSE CSSS (2014-2019) and Thapar Institute Merit Scholarship (2018) 🎖️. Honored with the Young Achiever Award (2021) 🌟, she excelled in research, winning Best Oral Presentation at EMSD-2022 🗣️ and Best Poster Award at CEEMS Doctorate Scholar’s Day-2024 🖼️. Her work on carbon quantum dots for metal ion detection highlights her expertise in materials science and sensors 🔬⚛️.

Publication Profile

Orcid

Education

Dr. Lei Tong 🏮🔬 is a dedicated research assistant at the Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences (since August 2023). With a strong academic foundation, Dr. Tong earned a Ph.D. (2018-2023) and a Bachelor’s degree (2014-2018) from the University of Science and Technology Beijing 🎓. His research integrates traditional Chinese medicine with modern scientific methodologies, contributing to innovative medical advancements. Passionate about bridging ancient wisdom with contemporary research, Dr. Tong continues to explore fundamental theories in Chinese medicine to enhance healthcare solutions. 🌿📚🔎

Research

Dr. Lei Tong focuses on integrating stem cells, organoids, microfluidic chips, and single-cell omics 🧬🔬 to develop a multi-organoid chip model for understanding disease and syndrome interactions in Traditional Chinese Medicine (TCM) 🌿. This innovative approach deciphers the spatio-temporal evolution of TCM syndromes and their biological basis. Additionally, Dr. Tong utilizes chromatogram-mass spectrometry, bioinformatics, and metabolomics 🧪📊 to identify active components in classic prescriptions, tracing their path to the brain 🧠. His research unveils the multi-component, multi-cell, multi-target neuroprotective mechanisms of TCM, offering new insights into holistic healing and modern medical applications. 🌍💊

Project

Dr. Lei Tong is actively engaged in pioneering research in Traditional Chinese Medicine (TCM) 🌿🔬. He leads multiple prestigious projects, including the Youth Project of Beijing Natural Science Foundation (2024-2026) 🏅, and the Science and Technology Innovation Project of the China Academy of Chinese Medical Sciences (2023-2025) 💡. Additionally, he is part of the Special Project for Training Outstanding Young Scientific and Technological Talents (2023-2026) 🎓 and a key researcher at the Research Institute of Basic Theories of TCM (2024-2027) 📚. His work contributes to advancing innovative technologies and methodologies in TCM for future medical breakthroughs 🌏✨.

Research Focus

Dr. Lei Tong’s research primarily focuses on neurodegenerative diseases 🧠🦠, particularly Parkinson’s disease (PD) 🏥🧬. His work explores novel therapeutic strategies, including herbal medicine 🌿, stem cell therapy 🧑‍🔬🧫, and nanotechnology-based drug delivery 💊🔬. He investigates neuronal synaptic plasticity 🔗, oligodendrocyte apoptosis ⚡, and inflammation control 🔥 to mitigate PD progression. Additionally, his studies extend to brain organoids 🏗️🧠 for drug discovery and protein aggregation targeting 🏹 in neurodegeneration. His interdisciplinary approach also includes fluorescent sensing 🟣🔍 for cellular applications. Dr. Tong’s research bridges neuroscience, regenerative medicine, and nanotechnology for innovative neuroprotection strategies. 🚀

Publication Top Notes

Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases.

Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson’s Disease.

Targeting small heat shock proteins to degrade aggregates as a potential strategy in neurodegenerative diseases.

Human gingival mesenchymal stem cells improve movement disorders and tyrosine hydroxylase neuronal damage in Parkinson disease rats.

A porphyrin-triazatruxene dyad for ratiometric two-photon fluorescent sensing of intracellular viscosity.

Hydrogel supplemented with human platelet lysate enhances multi-lineage differentiation of mesenchymal stem cells.

Chitosan Hydrogel Supplemented with Metformin Promotes Neuron-like Cell Differentiation of Gingival Mesenchymal Stem Cells.

Comparative proteomics analysis of human stem cells from dental gingival and periodontal ligament.

 

 

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Federico Bozzetti | Medicine and Health Sciences | Best Researcher Award

Dr Federico Bozzetti, ASLC, Italy

Dr. Federico Bozzetti is an esteemed Italian physician and specialist in oncology and surgery, born in Milan, Italy. He completed his studies at the University of Milan, University of Florence, and University of Pavia, followed by specialized training at renowned institutions like Lund University and Columbia University. With over 710 publications, including articles on cancer nutrition and home parenteral nutrition, Dr. Bozzetti is a leader in gastrointestinal oncology and artificial nutrition. He has held significant roles in prestigious societies, including as President of ESPEN. His research focuses on cancer treatment, liver transplantation, and cancer-related malnutrition.

Publication Profile

Orcid

Educational Background

Dr. Federico Bozzetti is a distinguished medical professional with multiple specializations in medicine, surgery, oncology, and epidemiology, earned from prestigious institutions such as the University of Milan, University of Pavia, and University of Florence 🎓🏥. Known for his academic excellence, he graduated with cum laude honors and achieved top scores in various examinations 🌟📚. Dr. Bozzetti’s vast expertise in medicine and cancer care has significantly impacted the field, reflecting his dedication to both clinical practice and research 🔬💉. His contributions continue to shape advancements in healthcare, particularly in oncology and epidemiology 🌍💪.

Experience

Dr. Federico Bozzetti is a renowned expert in cancer treatment and nutritional support. He has held leadership roles at prestigious institutions, including the Istituto Nazionale per lo Studio e la Cura dei Tumori in Milan. His groundbreaking research and clinical contributions have greatly advanced cancer care, particularly in the areas of nutrition for cancer patients. With a deep commitment to improving patient outcomes, Dr. Bozzetti’s work continues to inspire and shape the future of oncology and supportive care.

Global Influence

Dr. Bozzetti is a highly influential figure in the field of parenteral and enteral nutrition. His active involvement in numerous professional societies showcases his global impact. He is a founder and key member of both the European and Italian Societies of Parenteral and Enteral Nutrition (ESPEN and ISPEN). In addition to his contributions to these societies, Dr. Bozzetti plays a significant role in international collaborations, further advancing the field. He is also an esteemed member of various editorial boards, enhancing the scientific community with his expertise. 🌍🍽️📚💡🌱

Research Focus

Dr. Federico Bozzetti’s research primarily focuses on clinical nutrition, particularly in the context of cancer patients and those requiring specialized nutrition support. His work explores the role of physical exercise in improving outcomes for advanced cancer patients undergoing systemic therapy, as well as the challenges and outcomes of home enteral nutrition for patients and caregivers. Dr. Bozzetti also revisits the importance of nutrition for malnourished cancer patients, and he contributes to guidelines on home parenteral nutrition. His research seeks to improve patient care through better understanding of nutritional needs and therapy during illness. 🍽️🏥💪📚

Publication top Notes

Potential Benefits from Physical Exercise in Advanced Cancer Patients Undergoing Systemic Therapy? A Narrative Review of the Randomized Clinical Trials

Patients’ and caregivers’ perspective on challenges and outcomes with tube feeding: Analysis of home enteral nutrition survey data

The role of the nutrition in malnourished cancer patients: Revisiting an old dilemma

ESPEN practical guideline: Home parenteral nutrition

How to deal with micronutrient product shortage – Editorial

Cost of HPN in incurable cancer patients: Author’s response re. “SINPE Position Paper on the use of home parenteral nutrition in cancer patients”

A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer

Does nutrition support during chemotherapy increase long-term survival of cancer patients? Lessons from the past and future perspectives

TEMPORARY REMOVAL: SINPE Position Paper on the use of home parenteral nutrition in cancer patients

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Assist Prof Dr Russka Shumnalieva, Medical University-Sofia, Bulgaria, Bulgaria

Based on the details provided, Assist. Prof. Dr. Russka Shumnalieva appears to be a strong candidate for a Best Researcher Award.

Publication profile 

Orcid

  1. Expertise in Rheumatology: Dr. Shumnalieva has extensive experience in rheumatology, working at the largest university clinic for rheumatic diseases in Bulgaria. Her PhD thesis focuses on epigenetic modifications and their relation to rheumatic diseases, demonstrating in-depth research in disease mechanisms.
  2. Clinical Integration: Her research not only addresses theoretical aspects but also their application in clinical practice. Her work includes utilizing advanced techniques such as MSUS, capillaroscopy, and mini-invasive arthroscopy, showcasing her hands-on expertise in treating and monitoring patients.
  3. Translational Medicine Experience: Her fellowship at GBRC (Glasgow) and AMC (Amsterdam) provided her valuable experience in translational medicine, bridging the gap between laboratory research and clinical application.
  4. COVID-19 Research Contributions: Dr. Shumnalieva has co-authored significant research papers in top-tier journals, contributing to global studies on COVID-19 and its impact on autoimmune diseases, which underscores her relevance in current medical challenges.
  5. Multidisciplinary Collaborations: Her publications involve multidisciplinary, international collaborations on critical topics such as coronary artery diseases in vasculitides, multimorbidity in inflammatory myopathies, and lung involvement in systemic sclerosis.
  6. Public Health and Patient Care: With a Master’s in Public Health, Dr. Shumnalieva also explores the correlation between risk factors and rheumatic diseases, adding a valuable population health perspective to her research.
  7. Publication Record: With a solid portfolio of peer-reviewed articles in highly respected journals like Rheumatology International and International Journal of Rheumatic Diseases, Dr. Shumnalieva’s research addresses critical issues like the effect of multimorbidity on quality of life and disease flares post-COVID-19 infection.

    Publication top notes

    Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study

    Management of Coronary Artery Diseases in Systemic Vasculitides: Complications and Strategies

    The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis

    Lung Involvement in Systemic Sclerosis—From Pathogenesis to Prediction

    Exploring the Role of the Microbiome in Rheumatoid Arthritis—A Critical Review

    In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care

    Conclusion

    Dr. Shumnalieva’s extensive research background, innovative approaches to rheumatology, and contributions to understanding the intersection of autoimmune diseases and COVID-19 make her a standout candidate for the Best Researcher Award.